Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heneghan

Showing results (401-410 of 1,528) with videos related to

Pageof 153
Sort By:
Expert Opinion on Pharmacotherapy|January 26, 2006
Cost-effectiveness of pharmacotherapy for autoimmune hepatitisMichael A Heneghan, Thawab Al-Chalabi, Ian G McFarlane
The American Journal of Medicine|October 7, 2004
Pure red cell aplasia following pegylated interferon alpha treatmentMurat O Arcasoy, Don C Rockey, Michael A Heneghan
The New England Journal of Medicine|July 16, 2004
Management of cirrhosis and ascitesJames P O'Beirne, Matthew R Foxton, Michael A Heneghan
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Assessment of sleep/wake patterns using a non-contact biomotion sensorPhilip de Chazal, Emer O'Hare, Niall Fox, et al.
Systematic Reviews|July 11, 2013
Physical activity for the prevention and treatment of major chronic disease: an overview of systematic reviewsDavid Nunan, Kamal R Mahtani, Nia Roberts, et al.
Hepatology (Baltimore, Md.)|July 21, 2012
Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New ZealandMohamed I F Shariff, James Maggs, Michael A Heneghan
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2002
Heterogeneous nucleation of supercooled water, and the effect of an added catalystA F Heneghan, P W Wilson, A D J Haymet
Alimentary Pharmacology & Therapeutics|November 19, 2021
Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver diseaseJeremy S Nayagam, Michael A Heneghan, Marianne Samyn, et al.
Alimentary Pharmacology & Therapeutics|January 18, 2022
Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' replyJeremy S Nayagam, Michael A Heneghan, Marianne Samyn, et al.
Musculoskeletal Care|October 20, 2021
Group and individual telehealth for chronic musculoskeletal pain: A scoping reviewL M Wallace, D Falla, A Rushton, et al.
Pageof 153

Showing results (401-410 of 1,528) with videos related to

Sort By:
Pageof 153
Expert Opinion on Pharmacotherapy|January 26, 2006
Cost-effectiveness of pharmacotherapy for autoimmune hepatitisMichael A Heneghan, Thawab Al-Chalabi, Ian G McFarlane
The American Journal of Medicine|October 7, 2004
Pure red cell aplasia following pegylated interferon alpha treatmentMurat O Arcasoy, Don C Rockey, Michael A Heneghan
The New England Journal of Medicine|July 16, 2004
Management of cirrhosis and ascitesJames P O'Beirne, Matthew R Foxton, Michael A Heneghan
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Assessment of sleep/wake patterns using a non-contact biomotion sensorPhilip de Chazal, Emer O'Hare, Niall Fox, et al.
Systematic Reviews|July 11, 2013
Physical activity for the prevention and treatment of major chronic disease: an overview of systematic reviewsDavid Nunan, Kamal R Mahtani, Nia Roberts, et al.
Hepatology (Baltimore, Md.)|July 21, 2012
Mortality and the risk of malignancy in autoimmune liver diseases: a population-based study in Canterbury, New ZealandMohamed I F Shariff, James Maggs, Michael A Heneghan
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2002
Heterogeneous nucleation of supercooled water, and the effect of an added catalystA F Heneghan, P W Wilson, A D J Haymet
Alimentary Pharmacology & Therapeutics|November 19, 2021
Epstein-Barr virus status and immunosuppression use in paediatric autoimmune liver diseaseJeremy S Nayagam, Michael A Heneghan, Marianne Samyn, et al.
Alimentary Pharmacology & Therapeutics|January 18, 2022
Editorial: testing for Epstein Barr virus and treating autoimmune hepatitis-still a long way to go! Authors' replyJeremy S Nayagam, Michael A Heneghan, Marianne Samyn, et al.
Musculoskeletal Care|October 20, 2021
Group and individual telehealth for chronic musculoskeletal pain: A scoping reviewL M Wallace, D Falla, A Rushton, et al.
Pageof 153